PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
18.22%
Some net income increase while MRVL is negative at -37.39%. John Neff would see a short-term edge over the struggling competitor.
1.03%
Less D&A growth vs. MRVL's 34.53%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative yoy SBC while MRVL is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
70.93%
Well above MRVL's 123.86% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-100.00%
AR is negative yoy while MRVL is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-153.57%
Both reduce yoy inventory, with MRVL at -118.87%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
100.00%
AP growth of 100.00% while MRVL is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
60.21%
Lower 'other working capital' growth vs. MRVL's 123.48%. David Dodd would see fewer unexpected short-term demands on cash.
686.67%
Well above MRVL's 17.89%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
62.09%
Operating cash flow growth below 50% of MRVL's 260.57%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
2.79%
Some CapEx rise while MRVL is negative at -69.70%. John Neff would see competitor possibly building capacity while we hold back expansions.
100.00%
Some acquisitions while MRVL is negative at -970.70%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
-74.50%
Both yoy lines negative, with MRVL at -46.35%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
51.73%
We have some liquidation growth while MRVL is negative at -88.65%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-200.00%
We reduce yoy other investing while MRVL is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-188.64%
Both yoy lines negative, with MRVL at -389.15%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
142.86%
Stock issuance far above MRVL's 110.53%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
13.42%
Buyback growth of 13.42% while MRVL is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.